Survival of Plasmodium falciparum in human blood during refrigeration

Transfusion

Volumn 51, Issue 3, 2011, Pages 630-635

  Chattopadhyay, Rana ^a   Majam, Victoria F ^a   Kumar, Sanjai ^a  

^a OBRR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD; BLOOD SAMPLING; CELL CULTURE; CONTROLLED STUDY; ERYTHROCYTE; FREEZING; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW TEMPERATURE; MICROSCOPY; NONHUMAN; PARASITE DEVELOPMENT; PARASITE SURVIVAL; PARASITEMIA; PLASMODIUM FALCIPARUM;

BLOOD PRESERVATION; HUMANS; PARASITEMIA; PLASMODIUM FALCIPARUM; REFRIGERATION;

EID: 79952477471     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02872.x     Document Type: Article

References (17)

1. Woolsey G. Transfusion for pernicious anaemia. Ann Surg 1911;53:132-5.
2. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001;344:1973-8.
3. Shah S, Filler S, Causer LM Rowe AK, Bloland PB, Barber AM, Roberts JM, Desai MR, Parise ME, Steketee RW. Malaria surveillance - United States, 2002. MMWR Surveill Summ 2004;53:21-34.
4. Eliades MJ, Shah S, Nguyen-Dinh P, Newman RD, Barber AM, Roberts JM, Mali S, Parise ME, Steketee R. Malaria surveillance - United States, 2003. MMWR Surveill Summ 2005;54:25-40.
5. Mali S, Steele S, Slutsker L, Arguin PM. Malaria surveillance - United States, 2007. MMWR Surveill Summ 2009;58:1-16.
6. Fiebig EW, Busch MP. Emerging infections in transfusion medicine. Clin Lab Med 2004;24:797-823. (Pubitemid 39485874)
7. Stramer SL. Viral diagnostics in the arena of blood donor screening. Vox Sang 2004;87(Suppl 2):180-3.
8. Garraud O, Assal A, Pelletier B, Danic B, Kerleguer A, David B, Joussement M, de Micco P. Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008;95:226-31.
9. Kitchen AD, Chiodini PL. Malaria and blood transfusion. Vox Sang 2006;90:77-84. (Pubitemid 43381494)
10. Food and Drug Administration. Recommendations for deferral of donors for malaria risk: letter to all registered blood establishments. Food and Drug Administration: Washington, D.C; 1994.
11. Grant DB, Perinpanayagam MS, Shute PG, Zeitlin RA. A case of malignant tertian (Plasmodium falciparum) malaria after blood-transfusion. Lancet 1960;2:469-70.
12. Grellier P, Santus R, Mouray E, Agmon V, Mazière JC, Rigomier D, Dagan A, Gatt S, Schrével J. Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang 1997;72:211-20. (Pubitemid 27277713)
13. Haynes JD, Moch JK. Automated synchronization of Plasmodium falciparum parasites by culture in a temperature-cycling incubator. Methods Mol Med 2002;72:489-97.
14. Bruce-Chwatt LJ. DNA probes for malaria diagnosis. Lancet 1984;1:795.
15. Leiby DA, Nguyen ML, Notari EP. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008;48:2222-8.
16. Spencer B, Steele W, Custer B, Kleinman S, Cable R, Wilkinson S, Wright D. Risk for malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion 2009;49:2335-45.
17. Boyd MF, Kitchen SF. On the homogeneity of Plasmodium vivax infections acquired in highly endemic regions. Am J Trop Med Hyg 1948;28:29-34.